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idiopathic dilated cardiomyopathy is a disease of urn&a; 
etiology. One of the earliest studies of the natural history d 
disease (1) reported n31% l-year mortality Me and a 
atients with this disease 
identified at the Mayo Clinic between and fi973. 
cently published studies from this same i ution exami 
a populafion-based cohort with idiopathic dilated cardiomy- 
opathy identified in Olmsted County between 1975 and 1984, 
and reported an increasing incidence of the disease and a 
mortality rate that was significantly Lower (5% at 1 yem and 
20% at 5 years) than that reported in the earlier eferral 
cohort (2,3). Olmsted county is the county in which Roch- 
ester, Minnesota nd the Mayo Clinic are located. Ah 
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medical care for tbe 
matural history of ~dio~at 
each other and wit 
outcome of the current referral cohorts will also he: corn- 
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d with that of the popuIation_based cohort diagnosed at
institution between 1975 and 1984 (2) to determine 
the effkzt of referral bias on studies of the natural history of 
idiopathic dilated cardiomyopathy. 
!Patients with a diagnosis ofdilated cardiomyopathy at the 
aq Clinic between 1976 and 1987 were identified retrca- 
istory of heart failure, this 
abIe from the record and 
&as at the time of diagnosis were obtained 
from the medical record of that 
the recorded history, patients 
Heart Association functio 
was not complete enough 
the ba 
ncas in survival between these 
previously published referral 
orts were assessed by a ~~ut~~s~ 
comparison of survival curves based on ~~~~w~dq~ for- 
mula. Statistical significance implies ap value < 0.05 unless 
othe~~s~ tated. 
Folllow-up data were obtained on 222 patients with idio- 
thic dilated ~~diomyo~thy identified between 1976 and 
t&d between 1976 
between 1982 and 
1987. 
The clinical characteristics of the two referral groups are 
represented in Tabk 1. The mean and median age of the two 
cohorts were not different. Tbe 19764981 referra! cohort 
was “sicker” in that the patients were more symE;_umatic 
and had more signs of decompensated heart fake when 
f&t identified than did the patients inthe 1982-1987 referral 
cohort. The: 1976-1981 cohort was also more likely to have 
.6&X Vol. 2%. No. i 
*p 4 0.05. 6VCD = intraventricular conductim defect; SW = jugular 
venom pressure; NYMA class = New York &art Association funclionai 
chss: WCs = premature rentricuhr complexes. 
cardiomegnly an 
and median ejection 
. More patients in 
a serum sodium level 
< %37 mEq/liter, The ECG characteristics of the two groups 
were similar. 
The prevalence ofrisk factors for ventricular dysfunction 
such as alcohol abuse (5% to 7%), history of symptoms 
suggestive of myocarditis (16% to ES%), family history of 
idiopathic dilated cardiomyopathy (4% to 7%), history of 
rheumatic fever and diabetes mellitus was similar in the two 
cohorts. 
The pattern of medication use was assessed atthe time 
the patients were first identified and (w 
able) at the last subsequent visit to t 
the time the study questionnaire was distributed. Approxi- 
mately 65% of patients were taking digoxin amd diuretic 
drugs when first identified. No patient in the 1976-1981 
cohort and 20% of patients in the 1982-1987 cohort were 
receiving angiotensin-converting enzyme inhibitor therapy 
when first seen. ApprOXhmitely 50% of patients ineach cohort 
those in the 1982-8987 cohort were beiag treated 
ane~otensin-cotasre~~n~ enzyme inhibitors 
~~~~w~~~ questionnaire was returned, 50% 
rts were being treated with these agents. 
oronary artery disease was 
co~~~~ at cardiac beterizat~on in 156 patieats. TRe 
described in the current study (referral cohort 1976-1981 and 
referial cohort ~9$2-~~~7~ is depicted in Figure B. AB 
depicted are the survival curves from tkl: previolssly pu 
lisbed MO-1973 referral cohort and 
Bished population-bas 
dilated cardiomyopat 
tween 1975 and 1981. S 
referral cohort was n3t di 
described 1960-197: efe 
follow-up (p > O.ai_C!. Survival in the c’srrent ~9~~-~~~7 
referral cohort was better than that of the 1976-198 B rekrra[l 
cohort (p = 0.0002) and was significantly better than that of 
the previously published f960-1975 re 
points in 6 years of follow-up (p < OSX) 
in the previously published populatio 
r,ignificantly better than that of the 1982-8987 referral cohort 
at years 2 to 6 of foilow-up (p < 0.05). 
Figure 2 depicts the survival in the current referral 
cohorts in each New York I-kart Association functiona! 
class. As this figure shows, the improved survival in the 
more recent l982-1987 referral cohort when compared to tie: 
1976-1981 referral cohort appears to be strongest iathose 
patients who were in functiona! class I or II1 at the time of 
initial evaltiation. 
Several clinical, radi aphic and EC33 variables wet-k: 
examined as possible p cm5 of morta~ity~ Tbosc vati* 
ablf s that were ificant predictors ofmortality by univari- 
ate analysis alo ith the hazard r&s and confidence lewk 
are listed in Table 2. Using multivar&c analysis ofthcae and 
other selected variables, independent predictors ~~~~Or~~~~~ 
WCFC defined and are listed in Table 3. ~~~~ct~~~~~ &fist 
ejection fraction, diqaosis during the earlier stt@ 
(197&49$1), and the presence of a third heart soMi’id wWe 
independent predictors of mortality. Hmportant!y age, sex, 
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eeembcs PWkI92P-6 
nt 
with idiopathic dilated cardiomyopathy 
a 
a 
Figure I. Survival curves fur the four cohorts of 
parients with idiapath’ 
previously published 
previously reported population 
the ~9~~-~~$~ referral cob 
ral cohort, The numbers 
Figure 2. Survival curves for the 19764981 versus 
19824987 refwral cohorts by New York Heart Associ- 
ation (NYWA) functional c ass. The improved survival 
evident in the 19824P87 referral cohort was strongest 
for patients infunctional c asses I and II. 
arm% natural histwy ,Pf 
A recenti study by Co:id 
et al. (2) indicaled an increasing incidence of idiopathic 
dilated cardi0~~y~pat~y over two successive time periorls 
from 1975 to 1984. This finding was interpreted asindicating 
increasing recognitian and 
pathic dilated csrdiomys 
~ch~card~Qgra~~y and r 
vide objective vidence af systolic dys 
with indeterminate symptoms, a~I~~i~g 
thic dilated cardiomyopathy. 
ile ~ati~~lt§ in the 1982- 8‘7 cohort lived longer be- 
they were identified e er in the CCWS~ d their 
disease, the fact that diagnosis nthe 1976-1981 period was 
an in&q~~dent predictor of mortality indicates that 
other than early diagnosis are responsible f0r the im 
survival in the more recent cohort. ~rn~r~~~m~flts in treat- 
TabIe 3. Independent Predictors of Mortality by 
Multivariate Analysis 
P Hazard Confidence 
Chi-Square Value Ratio Limits 
NY HA class” 17.63 < O.H!Ql 1.63 1.29-2.06 
Ejection fraction? 13.74 0.0002 0.68 0.66-0.69 
Diagnosis in 1976 to 1981 11.93 0.0006 I .92 I .32-2.30 
S3 10.83 0.001 I.91 1.29-2.84 
*Hazard ratio reflects risk with an increase of one functional class. 
tHazard ratio reflects risk with an increase of IO percentage points. Abbre- 
viations as in Tables I and 2. 
24% 0f the I982-1198’7 referral co 
rny~~at~y c0~d~~ctcd in a referral populatio 
r&ml bias on studies of the natural histor 
conditions i  increasingly recognized (14, 
in, part to the k&hood that patients 
patients with a more fslvorable ~ro~~0~i 
examined in the currem study may be a ~~~~er pr~al~~~ce of 
0ther diseases in the referral population. 
Most large studies 0f the natural history of i 
ts im diagnosis and the 
failure (&IO,1 ,12,23) provide US@ 
sis in patients with ischcmic sad nonisc 
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cared for at referral institutions as part of a randomized trial, 
extrapolation of these data to patients with idiopathic dilated 
cdomyopathy not participating  clinical trials is not 
always appropriate, as suggested by the current s udy. 
ts Extensive data concerning 
cl c data were recorded in each 
patient and were xamined as possible predictors of 
mrtality. Using multivariate nalysis, only era of diagnosis 
(being in the earlier referral cohort), functional class, ejec- 
md the presence of a third heart sound were 
predictors of mortality. Despite the subjective 
~~~t~o~~ classificwtion and the inherent limie 
Not til p&Ms underwent coronary ~ngiog~~hy and
some pWMs may have had occult significant coronary 
artery disease. Patients who did not undergo corosnstry 
y were older, tended to be more symptomatic nd
signs of decompensated heti ftilurc than dad 
those who underwent coronztry 
wertz corrected for the severity 
their survivd WBS simile to th 
Thus, while one cannat CX- 
those with idi* 
thy 6123, their similu prognosis 
impressive that even though 
ct and subjective ariable, it 
of clinical course in idiopathic 
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